This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slipped 1.40% to $11.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.88% to 26,635.22 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.
The stock's fall snapped a four-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 41.73% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. (VNDA) fell 0.62% to $6.39, Fortress Biotech Inc. (FBIO) rose 3.14% to $2.30, and Viking Therapeutics Inc. (VKTX) rose 0.03% to $31.71.
Trading volume (217,857) remained 47,095 below its 50-day average volume of 264,952.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-14-26 1720ET

CRBP

IBBQ

LABU

SBIO

Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 1.40% to $11.98 on Thursday, ending a four-day winning streak, despite a strong overall market performance. The NASDAQ Composite rose 0.88% and the Dow Jones increased by 0.75%. Corbus's stock is currently 41.73% below its 52-week high of $20.56. In comparison, competitors Vanda Pharmaceuticals, Fortress Biotech, and Viking Therapeutics had mixed performances, with Fortress Biotech seeing a notable rise of 3.14%.

MarketWatch Automated

Corbus Pharma

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

NASDAQ Composite Index

Dow Jones Industrial Average

Vanda Pharma

Fortress Biotech

Viking Therap

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors